The dietary supplement, OxyElite Pro, made by USPLabs is ending distribution of the pill in response to an extremely high number of cases of liver failure, accord to Hawaii News Now.
The company has stated that it’s not aware of any connection between their supplements and liver failure but are investigating the issue further in coordination with the FDA and CDC.
The Hawaii Department of Health (DOH) is actively investigating 29 cases of acute hepatitis and liver failure that have occurred there since May of this year.
As of this time, the public is being advised to discontinue use of OxyElite Pro.
According to the FDA’s site, 24 of the 29 cases share a common link to OxyElite Pro and investigations are continuing in other parts of the nation. Symptoms of hepatitis include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay or gray-colored bowel movements, joint pain, yellow eyes, and jaundice.
Individuals who believe they are experiencing any of the symptoms above or may have been harmed by the dietary supplement are encouraged to contact their healthcare provider.
“Regrettably, patients taking the product may have been placed in harms way,” commented Megan McBride, an attorney investigating Tylenol lawsuits with the Levin, Papantonio law firm who practices in the areas or product liability and personal injury. “While the FDA is investigating the possible link between the drug and the illness, patients should do what they can to stay informed and consult a physician if they feel they may be suffering from the product.”
The FDA has sent out warnings earlier this year about drugs containing dimethylamylamine (DMAA), once it was discovered that there was a link between the drug and cases of severe illness and death. The company has stated that it hasn’t produced a version with DMAA in it since early 2013.